Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by Craiger02on Oct 29, 2021 10:24am
134 Views
Post# 34062974

RE:Don't kid yourself there is a raise coming , Tetra cash burn

RE:Don't kid yourself there is a raise coming , Tetra cash burn

Upon approval, there will be a significant jump in share price. That will then be followed up closely with another raise. Those funds will be utilized to prepare the drugs for market sale. That's when the share price will finally gain institutional buying and it will rise from there. That's why the warrants to me are the value play here. With expiration in 2024, you're betting on the future, not the present and locking in the exercise price while minimizing your risk.


SamV21 wrote: and with the warrants the company is betting the price will not go over .40 cents , that tells you how confident they are , have any of the warrants Tetra have issues ever been exersized . Even after any approval they have to promote for market share , they have no money to do that.That is what happens to drug companies , it takes money to make money , the price may go up but there will be another raise , bet on it.

 

<< Previous
Bullboard Posts
Next >>